Oral Endocannabinoids in People With Prediabetes and Diabetes

NCT06040164 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-09-15

No results posted yet for this study

Summary

This study evaluates the relationship of endocannabinoids in saliva with inflammation and oral dysbacteriosis present in people with periodontal disease and prediabetes/type 2 diabetes

Conditions

Interventions

OTHER

Observational study

No intervention will be performed

Sponsors & Collaborators

  • Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

    lead OTHER

Principal Investigators

  • Francisco J Bermúdez-Silva, PhD · Hospital Regional Universitario de Málaga - FIMABIS

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2024-06-30
Completion
2024-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06040164 on ClinicalTrials.gov